Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum

Malaria remains a major infectious disease and, despite incidence reduction, it threatens resurgence in drug-resistant forms. Antimalarial drugs remain the mainstay of therapeutic options and hence there is a constant need to identify and validate new druggable targets. Plasmodium falciparum aminoac...

Full description

Bibliographic Details
Main Authors: Manickam, Y, Chaturvedi, R, Babbar, P, Malhotra, N, Jain, V, Sharma, A
Format: Journal article
Language:English
Published: Elsevier 2018
_version_ 1826261073382080512
author Manickam, Y
Chaturvedi, R
Babbar, P
Malhotra, N
Jain, V
Sharma, A
author_facet Manickam, Y
Chaturvedi, R
Babbar, P
Malhotra, N
Jain, V
Sharma, A
author_sort Manickam, Y
collection OXFORD
description Malaria remains a major infectious disease and, despite incidence reduction, it threatens resurgence in drug-resistant forms. Antimalarial drugs remain the mainstay of therapeutic options and hence there is a constant need to identify and validate new druggable targets. Plasmodium falciparum aminoacyl-tRNA synthetases (Pf-aaRSs) drive protein translation and are potent targets for development of next-generation antimalarials. Here, we detail advances made in structural-biology-based investigations in Pf-aaRSs and discuss their distribution of druggable pockets. This review establishes a platform for systematic experimental dissection of malarial parasite aaRSs as a new focus for sustained drug development efforts against malaria.
first_indexed 2024-03-06T19:15:50Z
format Journal article
id oxford-uuid:1853ec10-9669-4ba1-b224-d914ed01f71f
institution University of Oxford
language English
last_indexed 2024-03-06T19:15:50Z
publishDate 2018
publisher Elsevier
record_format dspace
spelling oxford-uuid:1853ec10-9669-4ba1-b224-d914ed01f71f2022-03-26T10:42:42ZDrug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparumJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1853ec10-9669-4ba1-b224-d914ed01f71fEnglishSymplectic Elements at OxfordElsevier2018Manickam, YChaturvedi, RBabbar, PMalhotra, NJain, VSharma, AMalaria remains a major infectious disease and, despite incidence reduction, it threatens resurgence in drug-resistant forms. Antimalarial drugs remain the mainstay of therapeutic options and hence there is a constant need to identify and validate new druggable targets. Plasmodium falciparum aminoacyl-tRNA synthetases (Pf-aaRSs) drive protein translation and are potent targets for development of next-generation antimalarials. Here, we detail advances made in structural-biology-based investigations in Pf-aaRSs and discuss their distribution of druggable pockets. This review establishes a platform for systematic experimental dissection of malarial parasite aaRSs as a new focus for sustained drug development efforts against malaria.
spellingShingle Manickam, Y
Chaturvedi, R
Babbar, P
Malhotra, N
Jain, V
Sharma, A
Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
title Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
title_full Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
title_fullStr Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
title_full_unstemmed Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
title_short Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
title_sort drug targeting of one or more aminoacyl trna synthetase in the malaria parasite plasmodium falciparum
work_keys_str_mv AT manickamy drugtargetingofoneormoreaminoacyltrnasynthetaseinthemalariaparasiteplasmodiumfalciparum
AT chaturvedir drugtargetingofoneormoreaminoacyltrnasynthetaseinthemalariaparasiteplasmodiumfalciparum
AT babbarp drugtargetingofoneormoreaminoacyltrnasynthetaseinthemalariaparasiteplasmodiumfalciparum
AT malhotran drugtargetingofoneormoreaminoacyltrnasynthetaseinthemalariaparasiteplasmodiumfalciparum
AT jainv drugtargetingofoneormoreaminoacyltrnasynthetaseinthemalariaparasiteplasmodiumfalciparum
AT sharmaa drugtargetingofoneormoreaminoacyltrnasynthetaseinthemalariaparasiteplasmodiumfalciparum